BRIEF published on 06/18/2026 at 18:35, 24 days 12 hours ago Theraclion Reorganizes its Board of Directors Board Of Directors MedTech Theraclion Yann Duchesne Claude Lenoir
BRIEF published on 06/18/2026 at 18:35, 24 days 12 hours ago Theraclion Announces Changes in Board Leadership Executive Appointment Corporate Changes Board Evolution MedTech Leadership Theraclion Governance
PRESS RELEASE published on 06/18/2026 at 18:30, 24 days 12 hours ago Inside Information / Other news releases Theraclion announces changes in its Board of Directors with Mr. Yann Duchesne stepping down and new appointments made. New Interim Chairman appointed. Details on the company's MedTech advancements Board Of Directors MedTech Theraclion SONOVEIN HIFU
BRIEF published on 12/09/2025 at 18:35, 7 months 3 days ago Theraclion Submits Sonovein to FDA After Year of Key Achievements FDA Submission Clinical Evidence SONOVEIN Regulatory Achievements Varicose Vein Treatment
BRIEF published on 12/09/2025 at 18:35, 7 months 3 days ago Theraclion submits Sonovein to the FDA after significant progress FDA Theraclion SONOVEIN Varicose Veins HIFU
PRESS RELEASE published on 12/09/2025 at 18:30, 7 months 3 days ago Inside Information / Other news releases Theraclion announces FDA submission of Sonovein following a year of regulatory and clinical achievements. Key milestones in Europe and China also reached Clinical Milestones FDA Submission Theraclion SONOVEIN Regulatory Achievements
BRIEF published on 10/29/2025 at 18:35, 8 months 14 days ago Theraclion Announces 2025 Half-Year Financial Results and Strategic Progress Financial Results Revenue Growth Market Expansion U.S. Study Certification Progress
PRESS RELEASE published on 10/29/2025 at 18:30, 8 months 14 days ago Inside Information / News release on accounts, results Theraclion reports successful pivotal study, CE certification, GB 9706.1-2020 certification; 89% revenue increase and 23% operating loss reduction in 2025 half-year results Revenue Increase Operating Loss Reduction CE Certification Pivotal Study Theraclion
BRIEF published on 10/21/2025 at 18:35, 8 months 22 days ago Theraclion obtains crucial certification in China Medical Theraclion SONOVEIN® Focused Ultrasound Chinese Certification
BRIEF published on 10/10/2025 at 18:35, 9 months 2 days ago Monthly publication of Theraclion voting rights Share Capital Voting Rights Investment Euronext Growth Theraclion
Published on 07/13/2026 at 03:25, 3 hours 11 minutes ago SouthGobi Announces Inside Information JD Zhixing Fund L.P. Assigns Payment-In-Kind Interest Under Convertible Debenture
Published on 07/11/2026 at 02:50, 2 days 3 hours ago Alaska Energy Metals Reports on At-the-Market Equity Financing Program
Published on 07/11/2026 at 02:00, 2 days 4 hours ago Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te
Published on 07/11/2026 at 02:00, 2 days 4 hours ago Discovery Energy Metals Announces Non-Brokered Private Placement Financing
Published on 07/11/2026 at 00:00, 2 days 6 hours ago Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
Published on 07/11/2026 at 04:00, 2 days 2 hours ago CUHK Achieves Top 20 Global Ranking in QS World University Rankings 2027
Published on 07/10/2026 at 18:40, 2 days 11 hours ago AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives
Published on 07/10/2026 at 17:45, 2 days 12 hours ago WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026
Published on 07/10/2026 at 17:14, 2 days 13 hours ago Form 8.3 - SAFESTAY PLC: Opening Position Disclosure
Published on 07/10/2026 at 18:00, 2 days 12 hours ago Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 10:34, 2 days 20 hours ago Number of shares and voting rights - June 2026 (In French only)
Published on 07/09/2026 at 18:00, 3 days 12 hours ago Second-quarter 2026 activity: +7% (vs. Q2 2025)
